Table 3.
Comparison between laboratory parameters of alopecia areata patients and healthy control subjects
| Laboratory parameters | Alopecia areata | Control | P value |
|---|---|---|---|
| Patients, n | 50 | 50 | |
| WBCs 103/mm3 | 6.90 ± 1.63 | 6.00 ± 1.08 | 0.001* |
| Neutrophil (%) | 59.77 ± 7.31 | 58.73 ± 4.19 | 0.383 |
| Neutrophil count 103/mm3 | 4.60 ± 1.21 | 4.29 ± 0.69 | 0.121 |
| Lymphocyte (%) | 38.09 ± 7.59 | 35.34 ± 3.56 | 0.022* |
| Lymphocytes count 103/mm3 | 2.36 ± 0.55 | 2.14 ± 0.42 | 0.029* |
| NLR | 2.06 ± 0.80 | 2.09 ± 0.58 | 0.818 |
| Monocytes count 103/mm3 | 0.20 ± 0.06 | 0.22 ± 0.10 | 0.097 |
| Monocytes (%) | 3.61 ± 1.43 | 4.07 ± 0.99 | 0.065 |
| LMR | 13.18 ± 5.44 | 10.99 ± 3.94 | 0.023* |
| CD4+ T cells (%) | 33.95 ± 11.19 | 40.32 ± 6.42 | 0.001* |
| CD8+ T cells (%) | 23.38 ± 7.06 | 31.08 ± 5.05 | < 0.001* |
| CD4+/CD8+ ratio | 1.52 ± 0.33 | 1.31 ± 0.22 | 0.001* |
| CD56 bright CD16− (%) | 1.46 ± 0.57 | 1.81 ± 0.79 | 0.012* |
| CD56 bright CD16 + (%) | 10.10 ± 8.02 | 7.94 ± 4.02 | 0.092 |
| CD56 − CD16 + (%) | 6.62 ± 3.01 | 5.69 ± 2.16 | 0.081 |
WBCs, white blood cells; RBCs, red blood cells; NLR, neutrophil- lymphocytes ratio; LMR, lymphocyte-monocyte ratio; CD, cluster of differentiation
Values are expressed as means ± SD
*P value < 0.05 was considered statistically significant